Europe Conjugate Vaccines Market 2022 Analysis by Industry Growth and Research Report 2030 – Journal l’Action Régionale

Quadintel has published a new report on the European conjugate vaccine market. The research report contains detailed information about demand, growth, opportunities, challenges and restraints. Also, it provides an in-depth analysis of the structure and possibility of global and regional industries.

Conjugate vaccine is a type of vaccine that contains a bacterial capsular polysaccharide, attached with protein to enhance immunogenicity and protect against invasive disease. Europe is a stable growth market for conjugate vaccines.

The conjugate vaccines market in Europe is expected to grow at a CAGR of 3.6%, generating a revenue of USD 8.94 billion by 2023. In volume, it is expected to reach 504.46 million units of by 2023, growing at a CAGR of 3.7%.

The UK was the first country to introduce MenB-4C into its national infant immunization schedule (2015). In all EU/EEA countries, Hib vaccination has been part of vaccination programs since 2010, and high coverage has been maintained.

Request to download an example of this strategic report: –https://www.quadintel.com/request-sample/europe-conjugate-vaccine-market/QI042

Market segmentation :

oh Based on disease indicationthe market is segmented into pneumococci, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococci and others.

oh Based on end userthe market is segmented into pediatric and adult.

oh Country basedthe European market is divided into EU5 and Rest of EU.

Main growth factors:

The European market will not show extraordinary growth but average figures. The main growth factors include the growing importance and availability of funds for research and development. Additionally, advancements in medical science, awareness about the availability of more vaccines against diseases will drive the growth of this market. Increase in government vaccination programs, their initiatives and increase in research and development activities will drive the growth of this market.

Threats and key players:

o The European conjugate vaccines market is expected to grow at a sustained pace. Opportunities for significant growth are limited. Vaccine shortages are a major issue that will hamper the market growth. The shortage of vaccines affecting some EU/EEA Member States has had direct effects on the implementation of national vaccination programmes. Since 2015, nine EU/EEA Member States have had to adapt their vaccination policies.

o Major conjugate vaccine vendors operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

DOWNLOAD A FREE SAMPLE REPORThttps://www.quadintel.com/request-sample/europe-conjugate-vaccine-market/QI042

What is covered in the report?

1. Overview of the European Conjugate Vaccines Market
2. Market Drivers and Challenges in Europe Conjugate Vaccines Market
3. Market Trends in Europe Conjugate Vaccines Market
4. Historical, current and forecasted market size data for Europe based on disease indication (pneumococcus, haemophilus influenzae type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) in figures d business and volume
5. Historical, current and forecasted market size data for Europe based on end-user (pediatric and adult conjugate vaccines) by revenue and volume
6. Historical, current and forecasted country-based (EU5, Rest of EU) Conjugate Vaccines market size by revenue and volume
7. Historical, current and forecasted market size data for country segments by revenue and volume
8. Analysis of the competitive landscape and profiles of major companies operating in the European market

Why buy?

o Understand the demand for conjugate vaccines to determine market viability
o Understand country-specific market size and observations for each segment
o Develop strategies based on drivers, trends and highlights for each of the segments
o Evaluate the value stream to determine the workflow and get an idea of ​​the current position where you are placed
o Recognize the main competitors in this market and react accordingly
o Identify initiatives and growth strategies taken by major companies and decide on the direction of future growth
o Define competitive positioning by comparing products and services with key market players

The report further discusses market opportunities, compound annual growth rate (CAGR), competition, technological innovations, analysis of market players, government directives, export and import analysis (EXIM), historical revenues, future forecasts, etc. in the following regions. and/or country:

North America (US & Canada) Market Size, YOY Growth, Market Player Analysis and Opportunity Outlook
Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, annual growth and analysis of market players and opportunity outlook
Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands and Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of (Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, YoY Growth Market Player Analysis and Opportunity Outlook
Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, YoY Growth and Market Player Analysis and Outlook opportunities
Middle East & Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East & Africa) Market Size, YoY Growth Analysis market players and opportunity outlook

Ask for the complete report description, table of contents, table of figure, graph, etc. @-https://www.quadintel.com/request-sample/europe-conjugate-vaccine-market/QI042

Contents:

  • Market overview
  • Market definition and scope
  • Market dynamics
  • Market industry analysis
  • Market, regional analysis
  • Analysis of leading companies
  • Competitive intelligence
  • Research process
  • Market analysis and forecast, by product type

About Quadintel:

We are the best market research report provider in the industry. Quadintel believes in providing quality customer reporting to achieve revenue and bottom line goals, which will increase your market share in today’s competitive environment. Quadintel is a “one stop solution” for individuals, organizations and industries seeking innovative market research reports.

Contact us:

Quadintel:
Email: [email protected]
Address: Office – 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, USA
Tel: +1 888 212 3539 (USA – TOLL FREE)
Website:https://www.quadintel.com/